Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,000 across all filing types
Latest filing 2026-03-27 Annual Report
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
UCB SA_Management Report_Statutory Acccounts 2025_EN Final.pdf
Annual Report Classification · 1% confidence The document is titled 'Annual report of the Board of Directors' for the financial year ended 31 December 2025. It contains detailed financial information, including balance sheet items, profit and loss analysis, and dividend proposals for the parent company UCB SA/NV. While it references the 'UCB Group Integrated Annual Report 2025' for broader group-level details, this specific document serves as the statutory annual report for the parent entity, containing substantive financial data and management analysis. It is not a mere announcement (RPA) or certification (RNS), but a comprehensive financial report for the fiscal year. FY 2025
2026-03-27 English
UCB PR AGM Announcement March 27 2026 ENG.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is primarily an announcement convening the company’s Annual General Meeting of Shareholders, providing the agenda, participation formalities, and soliciting proxy votes on key items (board changes and dividend proposals). Although it also includes dividend details and board/management changes, the core purpose is to distribute meeting materials and request shareholder votes, which aligns with a Proxy Solicitation & Information Statement.
2026-03-27 English
UCB PR AGM Announcement March 27 2026 FR.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice convening UCB’s Annual General Meeting, including agenda items, board changes, proxy voting instructions, record date and dividend proposal. It is not the AGM presentation itself nor a full annual report, but rather the proxy/meeting materials sent to shareholders. This aligns with the definition of a Proxy Solicitation & Information Statement (PSI).
2026-03-27 French
UCB SA_Management Report_Statutory Accounts 2025_FR Final.pdf
Annual Report Classification · 1% confidence The document is titled 'Rapport annuel du Conseil d'Administration' (Annual Report of the Board of Directors) for UCB SA for the fiscal year ending December 31, 2025. It contains detailed financial information, including a balance sheet, income statement analysis, dividend proposals, and management commentary on financial performance. While it references an 'Integrated Annual Report' for consolidated group data, this specific document serves as the statutory annual report for the parent company (UCB SA) as required by Belgian law. It is not a mere announcement (RPA) or a certification, but a substantive financial report. FY 2025
2026-03-27 French
UCB SA_Proxy General Meeting 2026_FR - FINAL.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a proxy form (procuration) enabling shareholders to appoint a voting proxy and provide voting instructions for the company’s Annual General Meeting on 30 April 2026. It is materials sent to shareholders to solicit votes and instructions on resolutions, fitting the definition of a Proxy Solicitation & Information Statement (PSI).
2026-03-27 French
UCB SA_Report of the Statutory Auditor_FR_final.pdf
Audit Report / Information Classification · 1% confidence The document is titled “Rapport du commissaire à l’assemblée générale des actionnaires de UCB SA sur les comptes annuels pour l’exercice clos le 31 décembre 2025.” It contains the auditor’s opinion, key audit matters, responsibilities of management and auditor, and other audit-related disclosures. It is a standalone audit report on the annual financial statements, not the full annual report and not merely an announcement. This matches the definition of an Audit Report / Information (Code: AR). FY 2025
2026-03-27 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.